HomeNewsOpinionCOVID-19 | Courts making small steps towards accepting technology, but don’t expect a leap

COVID-19 | Courts making small steps towards accepting technology, but don’t expect a leap

A shift to online dispute resolution — hearings from remote locations, exclusively online filings — are likely to be discarded the moment the COVID-19 crisis passes

May 10, 2020 / 12:19 IST
Story continues below Advertisement

The nation-wide lockdown, in response to the coronavirus pandemic, has thrown up questions about the judiciary that were so far brushed under the carpet.

Take, for instance, undertrials in prisons. Many states have been mulling measures to temporarily release undertrials accused of petty offences for the reasons that over-crowded prisons had the potential to become mass-spreaders of the virus; jails are reportedly currently filled to 117 percent of its capacity. The question then asks itself — if yet-to-be convicted petty offenders can be granted bail now, why could they have not been granted the same earlier, when there was no crisis?

Story continues below Advertisement

Similarly, there has been a lot of noise around the Supreme Court and high courts hearing cases through video conferencing. While that is certainly a great first step, the cases taken up are few and far between, doesn’t appear to be scalable, and reserved only for the most urgent of cases. In fact, so typically of Indian courts, whether a bail plea was of the ‘most urgent’ nature itself was litigated immediately after, with the apex court staying a Rajasthan High Court decision to not list bail pleas as it was not an ‘extremely urgent matter’.

The fact is our courts were never prepared, or for that matter, never imagined the need to prepare, for such a prolonged lockdown. Worse, without a more professional approach, the lessons learnt from this crisis will remain on paper.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show